Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Capital Expenditures: 2012-2025

Historic Capital Expenditures for Aytu Biopharma (AYTU) over the last 10 years, with Jun 2025 value amounting to $228,000.

  • Aytu Biopharma's Capital Expenditures fell 94.83% to $17,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $228,000, marking a year-over-year increase of 101.32%. This contributed to the annual value of $228,000 for FY2025, which is 30.70% down from last year.
  • Latest data reveals that Aytu Biopharma reported Capital Expenditures of $228,000 as of FY2025, which was down 30.70% from $329,000 recorded in FY2024.
  • Over the past 5 years, Aytu Biopharma's Capital Expenditures peaked at $2.3 million during FY2021, and registered a low of $228,000 during FY2025.
  • Its 2-year average for Capital Expenditures is $278,500, with a median of $278,500 in 2024.
  • Data for Aytu Biopharma's Capital Expenditures shows a maximum YoY plummeted of 30.70% (in 2025) over the last 5 years.
  • Aytu Biopharma's Capital Expenditures (Yearly) stood at $2.3 million in 2021, then reached $329,000 in 2024, then crashed by 30.70% to $228,000 in 2025.